1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Heavy Metal Poisoning – Market Insights, Epidemiology, and Market Forecast-2030

Heavy Metal Poisoning – Market Insights, Epidemiology, and Market Forecast-2030

  • February 2021
  • 164 pages
  • ID: 6025271
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Heavy Metal Poisoning – Market Insights, Epidemiology, and Market Forecast-2030’ report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Heavy Metal Poisoning in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The heavy metal poisoning market report provides analysis regarding current treatment practices, emerging drugs like Emeramide, potential therapies, market share of the individual therapies, and historical, current and forecasted Heavy Metal Poisoning market size from 2017 to 2030, segmented by seven major markets.

The report also covers current heavy metal poisoning treatment practice/algorithm, guidelines, market drivers, market barriers, and unmet medical needs to curate best of the opportunities. It assesses the underlying potential of the market.

Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2017–2030

Heavy Metal Poisoning – Disease Understanding and Treatment Algorithm

Overview

Heavy metal poisoning is the accumulation of heavy metals, in toxic amounts, in the soft tissues of the body. Symptoms and physical findings associated with heavy metal poisoning vary according to the metal accumulated. Many of the heavy metals, such as zinc, copper, chromium, iron and manganese, are essential to body function in very small amounts. But, if these metals accumulate in the body in concentrations sufficient to cause poisoning, then serious damage may occur. The heavy metals most commonly associated with poisoning of humans are lead, mercury, arsenic and cadmium. Heavy metal poisoning may occur as a result of industrial exposure, air or water pollution, foods, medicines, improperly coated food containers, or the ingestion of lead-based paints.

Treatment

The main treatment of heavy metal poisoning is the termination of exposure to the metal. Treatment also consists of the use of various chelating agents that cause the toxic (poison) element to bind with the drug and be excreted in the urine. Three common drugs for the treatment of metal poisoning are BAL (dimercaprol), Calcium EDTA (calcium disodium versenate), and penicillamine. Each of these work by binding actions that permit the metals to be eliminated from the body through the urine.

Treatment should also be symptomatic and supportive. In some cases, the pumping of the stomach (gastric lavage) is used to remove some ingested metals. In the case of inhaled poisons, affected individuals should be removed from the contaminated environment and their respiration supported.
This chapter covers the details of conventional and current medical therapies available for the treatment of heavy metal poisoning. It also provides heavy metal poisoning treatment guidelines across the United States and Europe.

DelveInsight’s Heavy Metal Poisoning market report gives a thorough understanding of the disease by including details such as disease definition, symptoms, types, grading, pathophysiology, and diagnosis. It also provides heavy metal poisoning treatment algorithms and treatment guidelines in the US, Europe, and Japan.

Epidemiology:

The Heavy Metal Poisoning epidemiology chapters provide insights about historical and current heavy metal poisoning patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. Heavy metal poisoning epidemiology is segmented by total incident cases of heavy metal poisoning by age and by metal type. Besides, the report includes a thorough analysis of all segments.

According to the analyst analysis, the total prevalent population of heavy metal poisoning in seven major markets was 22,283 in 2020. These cases are expected to increase with a significant CAGR during the study period (2017–2030).

Among all the seven major markets, total prevalent cases for heavy metal poisoning were highest in the United States, followed by Japan. Spain accounted for the least number of prevalent cases among the 7MM.

Drug Chapters:

This segment encloses the detailed analysis of the drugs in the heavy metal poisoning pipeline. It also helps understand the Heavy Metal Poisoning clinical trial details, expressive pharmacological action, agreements of the included drug, and the latest news and press releases.

Currently, the main treatment of heavy metal poisoning is the termination of exposure to the metal. Treatment also consists of the use of various chelating agents that cause the toxic (poison) element to bind with the drug and be excreted in the urine. Trials of novel therapeutic agents are limited by the time taken to reach clinically significant endpoints.

Market Outlook:
The market size of heavy metal poisoning is expected to increase at a significant CAGR during the study period (2017–2030). Among all the seven major markets, the United States accounted for the largest Heavy metal poisoning market size. Among EU5 countries, Germany, in 2017, had the largest market size with USD 19.87 million, while Spain had the smallest market size of USD 2.13 million.

Drugs Uptake:
This section focuses on the rate of uptake of the potential drugs in the Heavy metal poisoning market or expected to get launched in the market during the study period 2017–2030. The analysis covers heavy metal poisoning market uptake by drugs patient uptake by therapies; and sale of each drug.

It helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size. All of which will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Emeramide (Emeramed) is a major player that will alter the market dynamics in the forecasted period 2020–2030.

Heavy metal poisoning: Pipeline Development Activities

The report provides insights into different therapeutic candidates and also analyses the key players involved in developing targeted therapeutics.

Pipeline Development Activities:

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details, and emerging therapies, concerning heavy metal poisoning.

KOL Views

To keep up with current market trends, we take KOLs and SME’s opinion working in heavy metal poisoning domain through primary research to fill the data gaps and validate our secondary research. It will support the clients in assessing potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We have performed the competitive and market Intelligence analysis of the heavy metal poisoning market by using various competitive intelligence tools that include SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies, etc. Besides, the inclusion of the analysis entirely depends upon the data availability.

Report Highlights:
• In the coming years, heavy metal poisoning market scenario is expected to experience a positive shift across the 7MM due to a robust pipeline.

• Our in-depth analysis of the pipeline assets across different stages of development (Phase II and Phase III), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Heavy Metal Poisoning Report Insights:
• Patient Population
• Therapeutic Approaches
• Heavy Metal Poisoning Pipeline Analysis
• Heavy Metal Poisoning Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Heavy Metal Poisoning Report Key Strengths:
• 11-year Forecast
• 7MM Coverage
• Heavy Metal Poisoning Epidemiology Segmentation
• Key Competitors
• Market Size by Therapies

• Drugs Uptake

Heavy Metal Poisoning Report Assessment:
• Pipeline Product Profiles
• Key Products and Key Players
• Market Drivers and Barriers

Key Questions

Market Insights:
• What was the heavy metal poisoning market share (%) distribution in 2020 and how it would look like in 2030?
• What would be the heavy metal poisoning total market size as well as market size by therapies across the 7MM during the forecast period (2017–2030)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest heavy metal poisoning market size during the forecast period (2017–2030)?
• At what CAGR, the heavy metal poisoning market is expected to grow in THE 7MM during the forecast period (2017–2030)?
• What would be the heavy metal poisoning market outlook across the 7MM during the forecast period (2017–2030)?
• What would be the heavy metal poisoning market growth till 2030, and what will be the resultant market Size in the year 2030?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:
• What are the disease risk, burden and unmet needs of heavy metal poisoning?
• What is the historical heavy metal poisoning patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of heavy metal poisoning in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM concerning the patient population pertaining to heavy metal poisoning?
• Out of all 7MM countries, which country would have the highest prevalent population of heavy metal poisoning during the forecast period (2017–2030)?
• At what CAGR the population is expected to grow in the 7MM during the forecast period (2017–2030)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:
• What are the current options for the heavy metal poisoning treatment, along with the approved therapy?
• What are the current treatment guidelines for the treatment of heavy metal poisoning in the USA, Europe, and Japan?
• How many companies are developing therapies for the treatment of heavy metal poisoning?
• How many therapies are developed by each company for heavy metal poisoning?
• How many are emerging therapies in mid-stage, and late stage of development for heavy metal poisoning treatment?
• What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the heavy metal poisoning therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for heavy metal poisoning and their status?
• What are the key designations that have been granted for the emerging therapies for heavy metal poisoning?
• What is the global historical and forecasted market of heavy metal poisoning?

Reasons to buy:
• The report will help in developing business strategies by understanding trends shaping and driving the heavy metal poisoning market
• To understand the future market competition in the heavy metal poisoning market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for heavy metal poisoning in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for heavy metal poisoning market
• To understand the future market competition in the Heavy Metal Poisoning market

Which geography accounted for the largest heavy metal poisoning market size?

The United States accounted for the largest heavy metal poisoning market size.

What is the forecasted Heavy Metal Poisoning market size in 2030?

The analyst estimates an increase in heavy metal poisoning market size during the study period, 2017–2030.
What are the present, heavy metal poisoning market drivers?
Targeting of Novel Pathways, Rising Investigations, Availability of Clear Diagnostics and Increasing Industrialization.
What are the heavy metal poisoning market barriers?
Standardized Treatment Routine, Rising Exposure Control Measures, Carcinogenic Risk and Irreversible Damage.
How many companies are developing drugs for Heavy Metal Poisoning?

Currently, key pharma players are developing the drug for heavy metal poisoning.

Which are the leading companies in the heavy metal poisoning market?

Key Players – Emeramed

How is epidemiology segmented for heavy metal poisoning?

It is segmented into total incident cases of heavy metal poisoning, age-specific cases of Heavy Metal Poisoning, and cases of heavy metal poisoning by metal type.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on